Pharma Journalist -

Concert Pharmaceuticals announced that it has completed patient enrollment of its Phase 2a trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata. The Company…
Read More...

Immune Therapeutics announced that the Kenya Pharmacy and Poison Board filed IMUN’s New Drug Application (NDA) for Lodonal, its lead drug candidate, thereby accepting the NDA for a full…
Read More...

Zoetis celebrated the start of construction on a combined global manufacturing and supply and research and development center in Suzhou, China, with a traditional groundbreaking…
Read More...

ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in funding from investment managers, Downing LLP. The funds will bolster the company’s business drive for faster…
Read More...

PAREXEL International Corporation announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018. Ms. Howell most recently served as…
Read More...

Lyophilization Services of New England (LSNE) announced that it has acquired PSC Biotech's cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin. This…
Read More...

AI genomics company Freenome announces its partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology.…
Read More...

Juniper Pharmaceuticals announced an exclusive worldwide license agreement with Daré Bioscience for the development and commercialization of the Company's intravaginal ring (IVR)…
Read More...

Innovus Pharmaceuticals announced the launch of its lidocaine-based cream Xyralid, for the relief of pain and symptoms caused by hemorrhoids. Xyralid received a Product License…
Read More...

The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the…
Read More...